NanoString Technologies

Seattle,  WA 
United States
  • Booth: 1401

NanoString is a life sciences company focused on cancer research and diagnostics. Proven in over 2,000 peer-reviewed publications, the nCounter® System can combine with 3D biology™ technology to create novel biomarkers. The Prosigna® Breast Cancer Prognostic Gene Signature Assay provides FDA 510(k)-cleared diagnostics with the nCounter Dx Analysis System.

For Technical Support with this webpage, please contact support